Extramural Funding & Training Opportunities

FOA Number: RFA-NR-23-001

Earliest Submission Date: October 22, 2022

Letter of Intent Due: October 22, 2022

Expiration Date: November 22, 2022

This Funding Opportunity Announcement (FOA) encourages UG3/UH3 phased cooperative research applications to accelerate implementation of effective non-opioid interventions for chronic pain management in rural and remote populations. Projects include pragmatic, implementation, or hybrid effectiveness-implementation trials to improve pain management and reduce the use of inappropriate opioid medications. Awards made under this FOA will initially support a milestone-driven, planning phase (UG3) of 1 to 2 years, with possible transition to an implementation phase (UH3) of up to 4 years duration (5 years total for the two phases). UG3 projects that have met the scientific milestone and feasibility requirements may transition to the UH3 phase. The UG3/UH3 application must be submitted as a single application, following the instructions described in this FOA.
 

The overall goal of this initiative is to support the "real world" implementation of effective interventions to manage pain in rural and remote areas. Results from the trials supported by this funding opportunity announcement (FOA) should inform policy makers, payers, community stakeholders, as well as health care providers and patients in the primary care, emergency department, hospital, home health, or dental settings. This FOA requires that the investigators partner with one or more rural healthcare system(s) to plan and implement the intervention. During the planning phase, investigators must develop an additional one or more community-based partnership(s). Studies may propose to integrate multi-component, bundled, or multi-level interventions that have demonstrated efficacy.
 

Trials will become part of and work with the HEAL Pragmatic and Implementation Studies to Improve the Management of Pain and Reduce Opioid Prescribing (PRISM) Program, which has leveraged the infrastructure of the NIH Pragmatic Trials Collaboratory, previously known as the NIH Health Care Systems (HCS) Research Collaboratory. (See https://rethinkingclinicaltrials.org/.) The PRISM Program has established a Coordinating Center (CC) that is providing national leadership and technical expertise in all aspects of research conducted within the Health Care Systems. Awarded applicants will work with the CC (http://rethinkingclinicaltrials.org/about-nih-collaboratory/) to facilitate further planning and refinement of the proposed study in partnership with health care delivery systems.

FOA Number: RFA-NS-22-053

Earliest Submission Date: October 4, 2022

Letter of Intent Due: 30 days prior to application due date

Expiration Date: November 5, 2022

The NIH has an FOA soliciting research applications that propose implementation science methodology to embed existing evidence-based coordinated pain care models into a variety of public and private health care systems (HCS) - where this type of care does not exist.  Applications that combine comparative effectiveness studies of innovative coordinated care models with strong implementation science methodology to embed effective approaches into HCSs also are encouraged. 

This FOA solicits applications from HCS who have resources and infrastructure to support research and implementation of study approaches in partnership with those HCS who lack research resources or experience and would benefit most from implementation of cost-effective coordinated pain care. HCS partners who serve populations that are under-represented in research are encouraged to apply.

Notice Number: NOT-NR-22-015

Estimated Publication Date of FOA: August 15, 2022

First Estimated Application Due Date: Nov. 15, 2022

Earliest Estimated Award/Start Date: July 1, 2023

FOA Number: RFA-AG-23-024

Earliest Submission Date & Letter of Intent Due Date: September 20, 2022

Policy and Alzheimer’s Disease (AD) and Alzheimer’s Disease-Related Dementias (ADRD) Healthcare Disparities: Access, Utilization, and Quality (R01 Clinical Trial Not Allowed)

RFA Release: anticipated June 13, 2022

Informational Webinar: June 29, 2022 @ 2pm ET. Register HERE

Applications Due: September 1, 2022 @ 5pm ET.

The NIA IMPACT Collaboratory plans to publish a RFA for CDA Program. The IMPACT Collaboratory plans to fund up to 2 CDAs in this cycle. For more information, click HERE.

RFA is expected to be published on June 13, 2022 on impactcollaboratory.org

Questions related to this funding opportunity? Contact IMPACTcollaboratory@hsl.harvard.edu

Notice Number: NOT-CA-22-077

Release Date: April 08, 2022 

Estimated Publication Date of Funding Opportunity Announcement: May 27, 2022 

First Estimated Application Due Date: September 01, 2022 

Earliest Estimated Award Date: July 01, 2023 

Earliest Estimated Start Date: July 30, 2023

NCI: Notice of Intent to Publish FOA

The National Cancer Institute (NCI) intends to publish a new funding opportunity regarding the needs of individuals living with advanced cancer.

Notice of Intent to Publish a Funding Opportunity Announcement for Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01 Clinical Trial Optional)

Open Date: Sept. 10, 2021

Expires: Feb. 14, 2024

PAR-21-308: Pragmatic Trials for Dementia Care and Caregiver Support (R61/R33 – Clinical Trial Required) 

This Funding Opportunity Announcement (FOA) will support pragmatic trials within Stage IV of the NIH Stage Model to improve dementia care across multiple dementia care settings that will: (1) be designed to address practical comparative questions faced by Alzheimer’s disease (AD) and AD-related dementia (ADRD) patients, clinicians, and caregivers (both paid and unpaid); (2) include broad and diverse populations; and (3) be conducted in real-world settings with adequate sample size. These trials are intended to produce results that can be directly adopted by healthcare providers, patients, or caregivers for rapid dissemination and implementation. Successful applications will: (1) improve quality of care of persons with dementia; (2) improve quality of life for persons with dementia and their informal caregivers; (3) deliver more patient-focused, cost-effective care across multiple settings; and/or (4) reduce disparities in dementia care.

This FOA will support Stage I or Stage III pilot research to test the feasibility of implementing and integrating interventions (R61 phase) that, if successful, can transition to an R33 phase (Stage IV) for implementation of large pragmatic trials.

The transition from the R61 to the R33 phase of the award will be administratively reviewed and determined by successful completion of the go/no-go criteria that are specified for the R61 phase.

Open Date: Sept. 10, 2021

Expires: Feb. 14, 2024

PAR-21-307: Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required) 

This Funding Opportunity Announcement (FOA) solicits mechanism-focused dementia care and caregiver support intervention development research at Stages I through V of the NIH Stage Model to address the care needs and promote the health, function, and well-being of persons with Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD) and of those providing their care. The NIH Stage Model offers a framework to: (1) support development of efficacious interventions that are defined by their principles; and (2) ensure that these efficacious interventions can be administered in the community or in health systems with fidelity to the intervention’s principles. This includes the development, testing, and validation of scalable training materials and procedures so that these interventions can be delivered with fidelity in community settings or health systems. Settings can include the home, community, or formal care settings, such as nursing homes, assisted living facilities, nursing and rehabilitation centers, hospitals, adult day care, and specialized hospice settings. The overarching purpose of this FOA is to help to lay the groundwork for real-world implementation of AD/ADRD care and caregiving interventions.

The principle-based interventions under development may target behavioral, psychological, interpersonal, social, or institutional processes and may be designed for use at the individual, family, dyad, group, community, or health-systems level. Applications may propose mechanism-focused intervention research for individuals living with dementia or for individuals or systems providing care for people at any stage of AD/ADRD. Applications proposing the development of interventions that address the principles underlying the care needs and challenges for individuals from diverse racial, ethnic, and socioeconomic backgrounds are strongly encouraged. Applications that involve interdisciplinary expertise and translational expertise (e.g., basic behavioral, social, psychological, or neurobiological science expertise relevant to hypothesized intervention mechanisms; expertise in the AD/ADRD service delivery system; and clinical psychological science expertise in areas outside of aging or AD/ADRD, but potentially relevant to AD/ADRD caregiver research, etc.) are also strongly encouraged. Applications may propose to create, modify, and test AD/ADRD care and caregiver support interventions based upon hypothesized mechanisms of action and are encouraged to incorporate a test of essential components or mechanisms of change using an appropriate methodological approach.

Application deadline: October 21, 2022

When:

Wednesday January 25th, 2023 from 11am-3:30pm ET 

Thursday January 26th 2023 from 11am-5pm ET

Apply Here!

NIA IMPACT Collaboratory 3rd Annual Training Workshop

Building Skills to Conduct Embedded Pragmatic Clinical Trials (ePCTs) among People Living with Dementia (PLWD) and their Care Partners

This 1.5-day virtual workshop features all new material to build a foundation in practical aspects of designing and conducting ePCTs in Alzheimer’s disease (AD) and AD-related dementias (ADRD). The workshop will include a combination of activities including: panel discussions, small group sessions, and networking opportunities with experts in the field. 

Eligibility Criteria:

• Applicants should have an MD, PhD, or equivalent research degree
• Hold a full-time position at an academic or research organization in the United States  
• Early-stage investigators pursuing careers conducting ePCTs in AD/ADRD
• Mid-career investigators seeking to pursue research on ePCTs in AD/ADRD

Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are encouraged to apply.

For more information, please click HERE

For follow up questions, contact Elaine Bergman, IMPACT Communications Lead at @elainebergman@hsl.harvard.edu

Attendance is limited to 36 participants and will be based on a competitive application process.  Members of the PCRC will be given some priority in the selection process. However, all research protocols must have an oncology focus.

Physicians, nurses, social workers, and psychologists who are early-stage researchers are eligible to attend. Participants must have a doctoral degree.

For more information and to apply, please visit  https://pallcare.hms.harvard.edu/courses/rmso.

Applications are due by September 7, 2022.

The Ninth Annual 

HARVARD MEDICAL SCHOOL WORKSHOP ON RESEARCH METHODS IN SUPPORTIVE ONCOLOGY (Jan 22-27, 2023)

This intensive 6-day workshop will provide an overview of fundamental methods, such as study designs, qualitative and survey methods, and approaches to data analysis in supportive oncology research. Over the course of the workshop, participants will write a complete study protocol under the direct mentorship of expert faculty in the field of supportive oncology. Participants will continue to receive assistance after the workshop from their workshop mentors to help in the implementation of their studies at their home institutions.

Essential workshop topics include: creation of conceptual models, supportive care clinical trials, development of psychosocial interventions, decision science, stakeholder engagement, web-based research, study of patient-provider communication, qualitative and survey methods, and data analysis.

Jennifer Temel, MD and William Pirl, MD, MPH will co-chair the workshop with a multidisciplinary team of faculty including: Joseph Greer, PhD; Elyse Park, MD, MPH; Lara Traeger, PhD; Lisa Wood, PhD; James Tulsky, MD; Areej El-Jawahri, MD; Joanne Wolfe, MD, MPH and others.

Rolling deadline

Applications are due by December 1, 2022 for start dates in 2023.

Funded by a Ruth Kirschstein National Research Service Award NRSA T32 from the National Institute on Aging (NIA), this Program builds on the significant Palliative Care expertise and research opportunities within the University of Colorado. Participants become members of the community of scholars at the University of Colorado and are provided with the full array of resources available within the Department of Medicine and the Colorado Clinical & Translational Sciences Institute (CCTSI).

More information about T32 opportunities at the University of Colorado

Palliative Care Post-Doctoral
Research Fellowship Programs Flyer

Application Due Date: February 1^st of desired start year

Candidates will be selected on a rolling basis each year until each of the two new slots per year are filled.

This 2-year Postdoctoral Training Program in Behavioral Geriatrics develops independent investigators capable of conducting patient-oriented research to improve the quality of life and quality of care of older adults. The  Program is co-led by Cary Reid, MD, PhD, Director of the Translational Research Institute on Pain in Later Life and Holly G. Prigerson, PhD, Director of the Center for Research on End-of-Life Care both based in the Department of Medicine, Division of Geriatrics and Palliative Medicine at Weill Cornell Medicine. Applications are accepted from both MD and PhD postdoctoral trainees (2/year) seeking careers at the intersection of biomedical and innovative social/behavioral approaches to improve care and care outcomes in older adults.

Please see the links below for more information:

• Behavioral Geriatrics T32 Flyer

• T32 Program Information

• Translational Research Institute for Pain in Later Life (TRIPLL)

• Weill Cornell Medical Center for Research on End-of-Life Care

Cambia Palliative Care Center of Excellence Palliative Care Research Fellowship Program

Fellowships will be 1-3 years in duration. Trainees must have an interest in palliative care research related to heart, lung or blood disease.

For more details and information about the Palliative Care Research Fellowship, please visit http://www.uwpalliativecarecenter.com
or email us at pallcntr@uw.edu